Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation
Monitoring of the JAK2 V617F allele burden in myeloproliferative neoplasms after allogeneic stem cell transplantation is useful to determine levels of residual disease and has the potential to detect early relapse and guide subsequent clinical intervention. A case is described of a JAK2 V617F-positi...
Saved in:
Main Authors: | Stephen E. Langabeer, James Nolan, Karl Haslam, Lindsey Clarke, Richard Flavin, Eibhlin Conneally |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2015/703457 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protracted Clonal Trajectory of a JAK2 V617F-Positive Myeloproliferative Neoplasm Developing during Long-Term Remission from Acute Myeloid Leukemia
by: Stephen E. Langabeer, et al.
Published: (2018-01-01) -
Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid
by: Kyohei Shibuta, et al.
Published: (2025-01-01) -
Assessing the contribution of myelofibrosis to a leukoerythroblastic blood picture
by: Stephen E. Langabeer
Published: (2025-01-01) -
Reconstructing skeletal homeostasis through allogeneic hematopoietic stem cell transplantation in myelofibrosis
by: Mathias Schäfersküpper, et al.
Published: (2025-01-01) -
Sigmoid Venous Thrombosis in JAK2 V617F Mutated Polycythemia Vera
by: Cilomar Martins De Oliveira Filho, et al.
Published: (2022-01-01)